Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-02-28 @ 11:59 PM
Study NCT ID:
NCT02501603
Status:
COMPLETED
Last Update Posted:
2023-01-27
First Post:
2015-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
Sponsor:
Yonsei University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
4-2015-0244
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None